Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study.
- Author:
Jingyi LI
1
;
Yunsheng LIANG
2
;
Wenli FENG
3
;
Liehua DENG
4
;
Hong FANG
5
;
Chao JI
6
;
Youkun LIN
7
;
Furen ZHANG
8
;
Rushan XIA
9
;
Chunlei ZHANG
10
;
Shuping GUO
11
;
Mao LIN
12
;
Yanling LI
13
;
Shoumin ZHANG
14
;
Xiaojing KANG
15
;
Liuqing CHEN
16
;
Zhiqiang SONG
17
;
Xu YAO
18
;
Chengxin LI
19
;
Xiuping HAN
20
;
Guoxiang GUO
21
;
Qing GUO
22
;
Xinsuo DUAN
23
;
Jie LI
24
;
Juan SU
24
;
Shanshan LI
25
;
Qing SUN
26
;
Juan TAO
27
;
Yangfeng DING
28
;
Danqi DENG
29
;
Fuqiu LI
30
;
Haiyun SUO
31
;
Shunquan WU
31
;
Jingbo QIU
31
;
Hongmei LUO
31
;
Linfeng LI
32
;
Ruoyu LI
33
Author Information
- Publication Type:Journal Article
- From: Chinese Medical Journal 2025;138(16):2040-2042
- CountryChina
- Language:English
